Select a medication above to begin.
Atgam
lymphocyte immune globulin, anti-thymocyte globulin (equine)
Black Box Warnings .
Anaphylaxis
can occur; monitor pts for s/sx during infusion and for at least 24h after infusion; D/C tx if anaphylaxis occurs; skin testing strongly recommended before 1st infusion; give serious consideration to alternative tx if positive skin test; admin. only in healthcare setting and by healthcare professional prepared for mgmt of anaphylaxis if proceeding tx w/ positive skin test; anaphylaxis may still occur in pts w/ negative skin test
Adult Dosing .
Dosage forms: INJ
kidney transplant rejection tx
- [10-15 mg/kg/dose IV qd x14 days]
- Info: intradermal skin testing recommended before first infusion; may cont. 10-15 mg/kg/dose IV qod up to 14 days (21 doses total)
aplastic anemia, mod-severe
- [10-20 mg/kg/dose IV qd x8-14 days]
- Info: for pts ineligible for bone marrow transplantation; intradermal skin testing recommended before first infusion; may cont. 10-20 mg/kg/dose IV qod up to 14 days (21 doses total); use lower start dose in pts 65 yo or older
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: INJ
kidney transplant rejection tx
- [10-15 mg/kg/dose IV qd x14 days]
- Info: intradermal skin testing recommended before first infusion; may cont. 10-15 mg/kg/dose IV qod up to 14 days (21 doses total)
aplastic anemia, mod-severe
- [10-20 mg/kg/dose IV qd IV x8-14 days]
- Info: for pts ineligible for bone marrow transplantation; intradermal skin testing recommended before first infusion; may cont. 10-20 mg/kg/dose IV qod up to 14 days (21 doses total)
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]